Genomate Health Appoints CEO to Lead Commercial Expansion

Genomate Health, a precision oncology company developing a new category of computational tools for Digital Drug Assignment (DDA) - a method using advanced computational reasoning to automatically match the most effective and personalized drug treatment to an individual patient's unique biological and clinical profile - announced today a major step in its growth with the appointment of CEO Nabil Hafez.

Read more: https://markets.financialcontent.com/ibtimes/article/accwirecq-2025-5-5-genomate-health-appoints-ceo-to-lead-commercial-expansion